Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery

• Status: Recruiting
• Trial end date: 2022-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to learn if there is a difference in recovery time when using sugammadex versus neostigmine. The researchers also hope to add further knowledge and data to the safety of using sugammadex in burn patients who are hypermetabolic.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Kansas Medical Center
• Treatments: Glycopyrrolate; Neostigmine

Criteria

Inclusion Criteria:

• Undergoing burn surgery under general anesthesia

Exclusion Criteria:

• Patients without a non-burned upper extremity

• Renal insufficiency or failure

• Sensitivity or hypersensitivity reaction to sugammadex

• Liver impairment, neuromuscular degenerative disease or dependence on drugs or alcohol